期刊文献+

阿魏酸钠双层片的制备及体外释放特性

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets
下载PDF
导出
摘要 目的:制备阿魏酸钠双层片并考察其体外释放特性。方法:采用粉末直接压片法,以羟丙基甲基纤维素(HPMC)为骨架材料制备阿魏酸钠双层片,通过紫外分光光度法,按照《中国药典》的转篮法测定体外释放度,并对体外药物释放的影响因素进行考察。结果:HPMC的规格和用量是影响药物释放的主要因素,填充剂不同对药物的释放也产生一定影响。结论:以HPMC K15M为骨架材料,微晶纤维素为填充剂制备的阿魏酸钠双层片具有良好的缓释和速释特性。 Objective: To prepare sodium ferulate double-layer tablets and study the drug release in vitro. Method: Sodium feru- late double-layer tablets were prepared using HPMC as the matrix by direct powder compression. UV- spectrophotometry and rotating basket method described in the Chinese Pharmacopeia (2010 edition) were used to determine the in vitro dissolution of sodium ferulate double-layer tablets and study the various influence factors. Result: The specification and amount of HPMC were the main impact fac- tors. The diluents showed effects on the drug release of the tablets as well. Conclusion: Sodium ferulate double-layer tablets based on HPMC K15M and microcrystalline cellulose have promising sustained and quick release properties.
出处 《中国药师》 CAS 2012年第6期808-810,共3页 China Pharmacist
关键词 阿魏酸钠 双层片 制备 体外释放 Sodium ferulate Double-layer tablets Preparation Release behavior in vitro
  • 相关文献

参考文献4

二级参考文献29

  • 1丁峰,朱家璧,周勤.阿比多尔双层缓释片的研制及体外释药[J].江苏药学与临床研究,2006,14(1):1-3. 被引量:4
  • 2黄国兴,季芳,杨文丹.川芎中阿魏酸的提取工艺研究[J].中国现代应用药学,2007,24(3):203-205. 被引量:5
  • 3中国药典[S].2010年版.二部.附录ⅨJ.
  • 4中国药典[S].2010年版.一部.39-40,189,32.
  • 5Mockel JE, Lippold BC. Zero-order drug release from hydrocolloid matrices[ J ]. Pharm Res, 1993,10:1066.
  • 6Ritger PL, Peppas NA. A simple equation description of solute release. I. fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs[J ]. J Controlled Release, 1987,5 : 23.
  • 7Moore JW, Flanner HH. Mathematical comparison of dissolution profiles[J]. Pharm Tech , 1996,6:64.
  • 8Notices, Federal Register [ S ]. 1995,60 (230) : 61642.
  • 9Malarnataris S, Ganderton D. Sustained release from matrix system comprising hydrophobic and hydrophilic (gel-forming) parts[J ]. Int J Pharm , 1991,70:69.
  • 10Ingani HM, Timmermans J, Moes AJ. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit [ J ]. Int J Pharm, 1987, 35 :157.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部